With ongoing guidance and personalized care, the team helps patients feel comfortable, informed, and prepared as they begin their weight loss journey
Preclinical studies in diet-induced obese (DIO) mice showed that once-weekly administration of the PEGylated GLP-1R/GcgR co-agonist for 1 month dramatically lowered body weight, compared with vehicle treatment [17]
Understanding GLP-1 for Weight Loss To understand the difference between a shot and a pill, it helps to understand exactly what a GLP-1 receptor agonist does
R.HenryR
Ahmann AJ, Capehorn M, Charpentier G, et al
However, clinical studies published in JAMA show that patients who discontinue Zepbound typically regain about 14% of their body weight, emphasizing that the medication is intended for long-term use as part of a comprehensive weight management approach